We present promising findings, in our sample consisting of only 70 BWLWH, that STEP-AD significantly increased ART adherence during the active intervention period, decreased the likelihood of a PTSD diagnosis, and improved CD4 count over time (baseline through T3). This evidence concerns the gene CD4 and post-traumatic stress disorder.